Loading...
Inflation And Regulatory Challenges Will Erode Biopharma Margins
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
-37.9%7D
0.7%1Y
-37.9%7D
0.7%You can edit this narrative until Aug 26 10:19 PM. Then, changes will post as Updates.
You can edit this narrative until Aug 26 10:19 PM. Then, changes will post as Updates.